A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Imatinib EP Impurity D - Request Quote

Picture of Imatinib EP Impurity D

Imatinib EP Impurity D

SZ CAT No:SZ-I004005
CAS No
NA
Mol.F.
C53H51N12O2 : Cl
Mol.Wt.
888.1 : 35.5
Inv. Status
In Stock
Rel. CAS No1821122-73-9 (Free base) ; 1821122-74-0 (Iodide salt)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Imatinib EP Impurity D is chemically 1-Methyl-1,4-bis(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazin-1-ium chloride. Imatinib EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Imatinib EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Imatinib EP Impurity D

Purchase Imatinib EP Impurity D

Imatinib EP Impurity D suppliers

Imatinib EP Impurity D manufacturers

Imatinib EP Impurity D price

Order Imatinib EP Impurity D

Enquire Imatinib EP Impurity D

Imatinib EP Impurity D cost

Imatinib EP Impurity D Supplier

Imatinib EP Impurity D Distributor

Imatinib EP Impurity D for Method Validation

Imatinib Reference Standard

Imatinib EP Impurity D for ANDA Filing

Imatinib EP Impurity D for Forced Degradation Studies

Imatinib EP Impurity D Identification Standards

Imatinib EP Impurity D for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,